Research Article
Expression of the Matrix Metalloproteases 2, 14, 24, and 25 and Tissue Inhibitor 3 as Potential Molecular Markers in Advanced Human Gastric Cancer
Table 1
Clinicopathological characteristics of patients with a diagnosis of gastric cancer included in the study.
| Characteristic | (%) |
| Age (years) | | Average ± standard deviation | 58 ± 12.4 | Range | 29–78 | Gender | | Feminine | 9 (52.9) | Masculine | 8 (47.1) | Histological type | | Adenocarcinoma | 17 (100) | Histological differentiation | | Well | 1 (5.9) | Moderate | 2 (11.8) | Poor | 11 (64.7) | Nondifferentiated | 1 (5.9) | Unknown | 2 (11.8) | Macroscopic classification | | Incipient | (0) | Advanced | 17 (100) | Size | | Less than 20 mm | (0) | 21–50 mm | 8 (47.1) | Greater than 50 mm | 9 (52.9) | Anatomic position (third) | | Upper | 4 (23.5) | Middle | 4 (23.5) | Lower | 6 (35.3) | Upper/middle | 1 (5.9) | Middle/lower | 1 (5.9) | Total | 1 (5.9) |
|
|